Treatment of newly diagnosed acute promyelocytic leukemia(APL):a comparison of French-Belgian-Swiss and PETHEMA results .Internatonal randomized study of interferon vs ST571(IRIS)8-year follow up:sustained survival and low risk for progression or events i ......